INR 100 UCLA Medical Plaza, Suites 205-210 Los Angeles, California 90095 (310) 824-6199 Edward Tobinick MD, Medical Director
Videos: Video 4 in Windows format or Quicktime format

Rapid improvement in Alzheimer's, beginning within minutes*

as seen on the BBC, New Scientist, CNN, Fox News, ABC News, Bloomberg News, Reuters Health, the Times Online (U.K.), the Daily Telegraph(U.K.), UPI, Medscape, in a university press release, and in Nature Clinical Practice Neurology

*see Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration Evaluation on Faculty of 1000 Biology, rating 9.0, exceptional (download PDF)

Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration Journal of Neuroinflammation 2008, 5:2 (download PDF)

Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease BMC Neurology 2008, 8:27 (download PDF)

Perispinal etanercept: Potential as an Alzheimer therapeutic JNI 2008, 5:3 (download PDF)

INR Memory Disorders Program - detailed brochure (download PDF)

This unique, unprecedented, patented[1] Alzheimer's treatment is available now in the U.S. exclusively at the INR® in Los Angeles and by INR® trained and licensed physicians.

Call today for appointments and information (310) 824-6199
The INR has an active Physician Training Program for medical doctors. For further information please click here.

<Map and Directions><Appointments><Terms of Use><Memory Disorders Program-detailed brochure (PDF)><Alzheimer treatment videos><Dementia><Citations to INR publications>
Copyright ©2008, the Institute for Neurological Research® (INR®), a private medical group, inc., all rights reserved. [1]U.S. patents 6,982,089 and 7,214,658, and additional issued and pending U.S. and foreign patents. These patents are assigned to TACT IP LLC. Please see the medical and legal disclaimer.

Perispinal etanercept for Alzheimer's disease and other forms of dementia (the Tobinick Method™) is a patented, off-label treatment method developed at the INR.